Penn Capital Management’s Bausch Health BHC Stock Holding History

Penn Capital Management’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-108,535	Closed	-$2.53M	–	191
2022 Q1	$2.53M	Buy	108,535 +2,232	+2%	+$54.6K	0.26%	99
2021 Q4	$2.94M	Sell	106,303 -3,590	-3%	-$96.1K	0.29%	103
2021 Q3	$3.06M	Sell	109,893 -1,099	-1%	-$31.2K	0.31%	93
2021 Q2	$3.25M	Buy	110,992 +26,433	+31%	+$801K	0.32%	95
2021 Q1	$2.68M	Buy	84,559 +476	+0.6%	+$14K	0.28%	109
2020 Q4	$1.75M	Buy	+84,083	New	+$1.57M	0.22%	133
2017 Q3	–	Sell	-28,631	Closed	-$495K	–	268
2017 Q2	$495K	Buy	+28,631	New	+$343K	0.04%	235
2016 Q4	–	Sell	-14,954	Closed	-$367K	–	285
2016 Q3	$367K	Buy	+14,954	New	+$387K	0.02%	258
2015 Q3	–	Sell	-2,250	Closed	-$500K	–	284
2015 Q2	$500K	Hold	2,250	–	–	0.02%	273
2015 Q1	$447K	Sell	2,250 -642	-22%	-$114K	0.02%	278
2014 Q4	$414K	Buy	+2,892	New	+$389K	0.02%	276

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Penn Capital Management's BHC Position: Q2 2022 in Review

Penn Capital Management sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 108,535 shares — an estimated $2.53M sold.

Penn Capital Management first reported a position in BHC in Q4 2014 and held it in 11 quarters. The position peaked at $3.25M in Q2 2021. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

Penn Capital Management reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
Penn Capital Management sold 108,535 Bausch Health shares in Q2 2022, an estimated $2.53M.
Penn Capital Management first reported a position in Bausch Health in Q4 2014 and held it in 11 quarters.
Penn Capital Management's Bausch Health position peaked at $3.25M in Q2 2021.
327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on Penn Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.